• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低收入和中等收入国家的肺动脉高压,重点关注撒哈拉以南非洲地区。

Pulmonary hypertension in low- and middle-income countries with focus on sub-Saharan Africa.

作者信息

Dzudie Anastase, Dzekem Bonaventure Suiru, Ojji Dike B, Kengne Andre Pascal, Mocumbi Ana Olga, Sliwa Karen, Thienemann Friedrich

机构信息

Departments of Internal Medicine and Physiology, Faculty of Medicine, University of Yaoundé, Yaoundé, Cameroon.

Departments of Internal Medicine and Cardiology, Douala General Hospital, Douala, Cameroon.

出版信息

Cardiovasc Diagn Ther. 2020 Apr;10(2):316-324. doi: 10.21037/cdt.2019.07.06.

DOI:10.21037/cdt.2019.07.06
PMID:32420114
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7225434/
Abstract

Pulmonary hypertension (PH) is a devastating, progressive disease with increasingly debilitating symptoms and usually shortened overall life expectancy. This article reviews the global epidemiology of PH with focus on low- and middle-income countries (LMICs) and sub-Sahara African in particular. Although left ventricular heart disease is the most common cause globally, the main contributing risk factors in LMICs are chronic infectious diseases especially human immunodeficiency virus (HIV) and schistosomiasis. Other important risk factors of PH are rheumatic heart disease, untreated congenital heart disease (CHD), and sickle cell disease. Despite existing epidemiological data of PH risk factors suggesting a high prevalence in sub-Saharan Africa (SSA), the available literature is limited. International registries in LMICs like the pan African pulmonary hypertension cohort (PAPUCO) study are essential to provide information about the causes, treatment, outcome, and the natural course of PH in Africa and other parts of the world. In addition, there is a need to track diagnostic and management practices in order to develop suitable algorithms to diagnose PH in LMICs.

摘要

肺动脉高压(PH)是一种具有破坏性的进行性疾病,症状日益使人衰弱,总体预期寿命通常缩短。本文回顾了PH的全球流行病学,重点关注低收入和中等收入国家(LMICs),特别是撒哈拉以南非洲地区。虽然左心室心脏病是全球最常见的病因,但LMICs中的主要促成风险因素是慢性传染病,尤其是人类免疫缺陷病毒(HIV)和血吸虫病。PH的其他重要风险因素包括风湿性心脏病、未经治疗的先天性心脏病(CHD)和镰状细胞病。尽管现有的关于PH风险因素的流行病学数据表明撒哈拉以南非洲(SSA)的患病率很高,但可用文献有限。像泛非肺动脉高压队列(PAPUCO)研究这样的LMICs国际注册对于提供有关非洲和世界其他地区PH的病因、治疗、结果和自然病程的信息至关重要。此外,有必要跟踪诊断和管理实践,以便开发适合LMICs的PH诊断算法。

相似文献

1
Pulmonary hypertension in low- and middle-income countries with focus on sub-Saharan Africa.低收入和中等收入国家的肺动脉高压,重点关注撒哈拉以南非洲地区。
Cardiovasc Diagn Ther. 2020 Apr;10(2):316-324. doi: 10.21037/cdt.2019.07.06.
2
A global perspective on the epidemiology of pulmonary hypertension.肺动脉高压流行病学的全球视角。
Can J Cardiol. 2015 Apr;31(4):375-81. doi: 10.1016/j.cjca.2015.01.030. Epub 2015 Jan 29.
3
Rationale and design of the Pan African Pulmonary hypertension Cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa.泛非肺动脉高压队列(PAPUCO)研究的原理与设计:在非洲实施一项关于肺动脉高压的当代注册研究。
BMJ Open. 2014 Oct 14;4(10):e005950. doi: 10.1136/bmjopen-2014-005950.
4
Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality.撒哈拉以南非洲地区的乳腺癌:降低死亡率面临的挑战与机遇
Oncologist. 2016 Jun;21(6):739-44. doi: 10.1634/theoncologist.2015-0429. Epub 2016 Apr 18.
5
The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry.非洲肺动脉高压的病因、治疗及预后:泛非肺动脉高压队列(PAPUCO)登记研究的见解
Int J Cardiol. 2016 Oct 15;221:205-11. doi: 10.1016/j.ijcard.2016.06.242. Epub 2016 Jun 29.
6
Tuberculosis结核病
7
Long-Term Follow-up of Human Immunodeficiency Virus-Associated Pulmonary Hypertension: Clinical Features and Survival Outcomes of the Pan Africa Pulmonary Hypertension Cohort (PAPUCO).人类免疫缺陷病毒相关肺动脉高压的长期随访:泛非肺动脉高压队列(PAPUCO)的临床特征与生存结局
Open Forum Infect Dis. 2022 Nov 28;9(12):ofac604. doi: 10.1093/ofid/ofac604. eCollection 2022 Dec.
8
Congenital heart disease in low-and-middle-income countries: Focus on sub-Saharan Africa.中低收入国家的先天性心脏病:以撒哈拉以南非洲为重点。
Am J Med Genet C Semin Med Genet. 2020 Mar;184(1):36-46. doi: 10.1002/ajmg.c.31769. Epub 2020 Feb 6.
9
m-Health Policy Readiness and Enabling Factors: Comparisons of Sub-Saharan Africa and Organization for Economic Cooperation and Development Countries.移动医疗政策准备情况和推动因素:撒哈拉以南非洲国家与经济合作与发展组织国家的比较。
Telemed J E Health. 2018 Nov;24(11):908-921. doi: 10.1089/tmj.2017.0278. Epub 2018 Feb 12.
10
Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countries.在撒哈拉以南非洲开展的已发表的随机试验侧重于高负担疾病,但这些试验通常由高收入国家资助和主导。
J Clin Epidemiol. 2017 Feb;82:29-36.e6. doi: 10.1016/j.jclinepi.2016.10.008. Epub 2016 Nov 16.

引用本文的文献

1
Global pulmonary arterial hypertension trends and projections to 2046: a multi-method analysis of epidemiologic and demographic drivers using GBD 2021.全球肺动脉高压趋势及2046年预测:利用全球疾病负担研究2021对流行病学和人口统计学驱动因素进行的多方法分析
J Thorac Dis. 2025 Jul 31;17(7):4420-4438. doi: 10.21037/jtd-2025-305. Epub 2025 Jul 28.
2
Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension.克隆性造血对肺动脉高压因果效应的遗传学证据。
BMC Cardiovasc Disord. 2025 Jan 23;25(1):38. doi: 10.1186/s12872-025-04475-4.
3
Prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary diseases patients at public hospitals of Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study.2024年埃塞俄比亚亚的斯亚贝巴公立医院慢性阻塞性肺疾病患者肺动脉高压的患病率及其相关因素:一项基于机构的横断面研究
Front Public Health. 2024 Nov 26;12:1456235. doi: 10.3389/fpubh.2024.1456235. eCollection 2024.
4
Exploring the patient perspective in pulmonary hypertension.探讨肺动脉高压中的患者视角。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01129-2024. Print 2024 Oct.
5
International trends in pulmonary hypertension mortality between 2001 and 2019: Retrospective analysis of the WHO mortality database.2001年至2019年肺动脉高压死亡率的国际趋势:对世界卫生组织死亡率数据库的回顾性分析
Heliyon. 2024 Feb 9;10(4):e26139. doi: 10.1016/j.heliyon.2024.e26139. eCollection 2024 Feb 29.
6
Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study.俄罗斯、哈萨克斯坦、土耳其、黎巴嫩和沙特阿拉伯慢性血栓栓塞性肺动脉高压的诊断与治疗模式:一项注册研究
Drugs Real World Outcomes. 2024 Mar;11(1):149-165. doi: 10.1007/s40801-023-00407-w. Epub 2024 Feb 21.
7
PULMOEAST: A Comprehensive Analysis of Pulmonary Hypertension in Eastern India.PULMOEAST:印度东部肺动脉高压综合分析
Cureus. 2023 Dec 23;15(12):e50996. doi: 10.7759/cureus.50996. eCollection 2023 Dec.
8
Unlocking the Secrets of Longevity: Exploring the Impact of Socioeconomic Factors and Health Resources on Life Expectancy in Oman and Qatar.解锁长寿之谜:探索阿曼和卡塔尔的社会经济因素和健康资源对预期寿命的影响。
Inquiry. 2023 Jan-Dec;60:469580231212224. doi: 10.1177/00469580231212224.
9
HIV status and survival of patients with pulmonary hypertension due to left heart disease: the Pan African Pulmonary Hypertension Cohort.HIV 状况和左心疾病所致肺动脉高压患者的生存情况:泛非肺动脉高压队列研究。
Sci Rep. 2023 Jun 16;13(1):9790. doi: 10.1038/s41598-023-36375-y.
10
Pulmonary hypertension among patients hospitalized with acute heart failure in Buea, South West Region of Cameroon.喀麦隆西南部布埃亚地区因急性心力衰竭住院患者的肺动脉高压。
Pan Afr Med J. 2022 Jul 20;42:216. doi: 10.11604/pamj.2022.42.216.33076. eCollection 2022.

本文引用的文献

1
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.血流动力学定义和肺动脉高压的最新临床分类。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
2
A diagnostic algorithm for pulmonary hypertension due to left heart disease in resource-limited settings: can busy clinicians adopt a simple, practical approach?资源有限环境下左心疾病所致肺动脉高压的诊断算法:忙碌的临床医生能否采用一种简单、实用的方法?
Cardiovasc J Afr. 2019;30(1):61-67. doi: 10.5830/CVJA-2018-042. Epub 2018 Nov 30.
3
Pulmonary hypertension as seen in a rural area in sub-Saharan Africa: high prevalence, late clinical presentation and a high short-term mortality rate during follow up.撒哈拉以南非洲农村地区的肺动脉高压:患病率高、临床症状出现晚且随访期间短期死亡率高。
Cardiovasc J Afr. 2018;29(4):208-212. doi: 10.5830/CVJA-2018-007. Epub 2018 Jul 7.
4
Prevalence and etiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis.非洲肺动脉高压的患病率和病因:系统评价和荟萃分析。
BMC Pulm Med. 2017 Dec 8;17(1):183. doi: 10.1186/s12890-017-0549-5.
5
Gender disparities in pulmonary hypertension at a tertiary centre in Cameroon.喀麦隆某三级医疗中心肺动脉高压的性别差异
S Afr Med J. 2017 Sep 22;107(10):892-899. doi: 10.7196/SAMJ.2017.v107i10.12321.
6
Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria.尼日利亚5至18岁镰状细胞贫血患儿的肺动脉高压
PLoS One. 2017 Sep 14;12(9):e0184287. doi: 10.1371/journal.pone.0184287. eCollection 2017.
7
Pulmonary hypertension: prevalence and risk factors.肺动脉高压:患病率及危险因素。
Int J Cardiol Heart Vasc. 2016 May 9;11:87-89. doi: 10.1016/j.ijcha.2016.05.012. eCollection 2016 Jun.
8
Pulmonary hypertension in Nigerian adults with sickle cell anemia.尼日利亚成年镰状细胞贫血患者的肺动脉高压
Vasc Health Risk Manag. 2017 May 8;13:153-160. doi: 10.2147/VHRM.S92799. eCollection 2017.
9
Non-Invasive Assessment of Pulmonary Vascular Resistance in Pulmonary Hypertension: Current Knowledge and Future Direction.肺动脉高压中肺血管阻力的无创评估:当前认知与未来方向
Heart Lung Circ. 2017 Apr;26(4):323-330. doi: 10.1016/j.hlc.2016.10.008. Epub 2016 Nov 20.
10
The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry.非洲肺动脉高压的病因、治疗及预后:泛非肺动脉高压队列(PAPUCO)登记研究的见解
Int J Cardiol. 2016 Oct 15;221:205-11. doi: 10.1016/j.ijcard.2016.06.242. Epub 2016 Jun 29.